Fs Credit Opportunities Stock Quote FSCO - Stock Price, News, Charts, Message Board, Trades

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NYSE
Fs Credit Opportunities Corp (FSCO) Quote

Fs Credit Opportunities Corp (FSCO)

6.27

0.07

( 1.13% )

Updated: 11:53:41

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

6.27

Bid

-

Ask

-

Volume

249,446

6.20 Day's Range 6.295

4.90 52 Week Range 6.64

Market Cap

Previous Close

6.20

Open

6.21

Last Trade

Last Trade Time

11:53:41

Financial Volume

$ 1,560,495

VWAP

6.2558

Average Volume (3m)

636,506

Shares Outstanding

198,355,900

Dividend Yield

11.15%

PE Ratio

5.12

Earnings Per Share (EPS)

1.22

Revenue

261.24M

Net Profit

242.94M

FS Credit Opportunities Corp. seeks to generate an attractive total return. Fund invests in non-traditional areas of the public and private credit markets where a yield or return premium may exist due to complexity, illiquidity or a result of corporate events. FS Credit Opportunities Corp. seeks to generate an attractive total return. Fund invests in non-traditional areas of the public and private credit markets where a yield or return premium may exist due to complexity, illiquidity or a result of corporate events.

Sector

Finance Services

Industry

Finance Services

Headquarters

Lutherville Timonium, Maryland, USA

Founded

1970

Fs Credit Opportunities Corp is listed in the Finance Services sector of the New York Stock Exchange with ticker FSCO. The last closing price for Fs Credit Opportunities was $6.20. Over the last year, Fs Credit Opportunities shares have traded in a share price range of $ 4.90 to $ 6.64.

Fs Credit Opportunities currently has 198,355,900 shares outstanding. The market capitalization of Fs Credit Opportunities is $1.23 billion. Fs Credit Opportunities has a price to earnings ratio (PE ratio) of 5.12.

Form 8-K - Current report

FS Credit Opportunities Corp. (FSCO) Declares Distribution for July 2024

FS Credit Opportunities Corp. (FSCO) Declares Distribution for July 2024 PR Newswire PHILADELPHIA, July 3, 2024 PHILADELPHIA, July 3, 2024 /PRNewswire/ -- The Board of Directors of FS Credit...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

FS Credit Opportunities Corp. (FSCO) Declares Distribution for June 2024

FS Credit Opportunities Corp. (FSCO) Declares Distribution for June 2024 PR Newswire PHILADELPHIA, June 3, 2024 PHILADELPHIA, June 3, 2024 /PRNewswire/ -- The Board of Directors of FS Credit...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.23	-3.53846153846	6.5	6.5299	6.17	1328376	6.25224873	CS
4	-0.1	-1.56985871272	6.37	6.64	6.17	861154	6.38073697	CS
12	0.41	6.99658703072	5.86	6.64	5.85	636506	6.31346149	CS
26	0.49	8.47750865052	5.78	6.64	5.61	651827	6.02993791	CS
52	1.35	27.4390243902	4.92	6.64	4.9	709873	5.74770594	CS
156	1.27	25.4	5	6.64	3.8	673231	5.32649234	CS
260	1.27	25.4	5	6.64	3.8	673231	5.32649234	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DCAPUnity Wealth Partners Dynamic Capital Appreciation & Options ETF	20.10 (839.25%)	128.72k
SLRXSalarius Pharmaceuticals Inc	$ 5.03 (226.62%)	41.19M
RGCRegencell Bioscience Holdings Ltd	$ 10.64 (215.73%)	85.36k
ADILAdial Pharmaceuticals Inc	$ 1.86 (75.47%)	143.78M
SPWRSunPower Corporation	$ 1.1247 (57.12%)	83.1M
JAGXJaguar Health Inc	$ 1.5406 (-63.92%)	9.55M
RNAZTransCode Therapeutics Inc	$ 0.2998 (-62.17%)	5.96M
FLYEFly E Group Inc	$ 2.75 (-56.90%)	5.42M
MIRAMIRA Pharmaceuticals Inc	$ 2.34 (-53.29%)	19.67M
CMAXCareMax Inc	$ 3.25 (-37.38%)	7.02M
ADILAdial Pharmaceuticals Inc	$ 1.86 (75.47%)	143.78M
SLNASelina Hospitality PLC	$ 0.0247 (-33.24%)	91.25M
ATPCAgape ATP Corporation	$ 0.19889 (39.08%)	89.74M
SPWRSunPower Corporation	$ 1.125 (57.17%)	83.11M
NVDANVIDIA Corporation	$ 123.62 (0.06%)	81.25M

hedge_fun

hedge_fun 4 minutes ago

While the SeaSearcher did not see any gold or silver on its initial scan of the Ring Site, it did identify numerous materials including brass, iron, copper, aluminum, lead, and stainless steel.”

https://seafarerexplorationcorp.com/seafarer-announces-second-generation-seasearcher-2/

doc2016

doc2016 4 minutes ago

me: does this sound like ploinks and puddle and the creator controls the app and ability to see/use it?
perplexity says:
Performance:
Uses NVIDIA-optimized embedding models for high accuracy
Achieves low latency (around 10ms) for embedding and indexing when used with NV

Hercules1

Hercules1 4 minutes ago

We got that performing monkeys infestation.

It is textbook stuff:

Paid performing monkeys doing their thing.

Nihil8

Nihil8 4 minutes ago

James Bond strikes again

theorysuit

theorysuit 5 minutes ago

I can't wait for whatever PUMP PR they put for this final pump and dump. It is going to be some laughable comedy that is justifed by the ihub pumpers.

tapioca

tapioca 5 minutes ago

What the hell are you talking about. "Kitty cat short squeeze",
useless.

otcsource

otcsource 5 minutes ago

Nobody cares! The same old news over and over again. Employees fine make the company private and pay them more.

georgejjl

georgejjl 5 minutes ago

Institutions are helping the upward price move for AVXL stock. The financial institutions have been and are continuing to buy AVXL today.

Good luck and GOD bless,

Carjockey2

Carjockey2 5 minutes ago

https://x.com/cocomoco1234567/status/1815780156016930896?t=ob1Wr9VUqHUDnPv04IatRw&s=19

Lolzzzz

Chester100

Chester100 6 minutes ago

Still here I see 👀

otcsource

otcsource 6 minutes ago

NO, Seriously nobody cares. Regurgitation of the same old news. Nobody cares.

ilovetech

ilovetech 6 minutes ago

Also important to keep in mind, how long new regulatory guidance took to establish RWE as viable, and or even preferable, from an ethical perspective for severe disease trials, which helps the recruiting efforts to enroll trial participants. Also keep in mind, that it was the regulators who required

drkazmd65

drkazmd65 7 minutes ago

Interesting move up this morning - volume is kind of light though for it to seem like anything 'real' is up.

just Scottie

just Scottie 7 minutes ago

You were saying!

Chromosome

Chromosome 7 minutes ago

Eagerly waiting Captains UK numbers but not knowing the full U.K. holiday schedule and all things being equal, looks like there are three fewer working days in June vs May. Add the typical summer slowdown, appropriate calibration may be in order.

SloGin

SloGin 7 minutes ago

Explain..(your comment)!!!

Direct from the favorite guy you guys love to bash & twist facts just posted on X

Yup the same one who brought the Australia Sheikh deal to $HIRU & HIRU backer / equipment financiers

https://tinyurl.com/4zna98a6

Acme Investments

Acme Investments 8 minutes ago

Reminds me of the first hill of the roller-coaster 🎢!! Tick...tick....tick....then drop!!

somberfox

somberfox 8 minutes ago

We're getting a watch man. Chilll.

JJZander

JJZander 8 minutes ago

We’ve now registered Synbio International Inc with the authorities in Florida. Just waiting on FINRA to approve the new ticker before using our new name. New name, new funding, new business. Looking forward to building value for the long-suffering shareholders of NHYF.

B_B!

B_B! 8 minutes ago

I think the Russell 2000 will double its gains today and save AMC.

BullNBear52

BullNBear52 8 minutes ago

I doubt the vet will let you have a cow. With my ailments I can eat anything and I feel sorry for what you must be going through.

Not sure I could do that.

martyDg

martyDg 8 minutes ago

No matter how revolutionary this is, all of this doesn't matter if the RA doesn't approve the vaccine. No matter how good it looks on paper, if the RA says no, then what are you going to do?

Fs Credit Opportunities

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions